Pediatric Cancers Targeted By Virus
Links shared publicly online about this topic.
- 33total visits
Pediatric Cancers Targeted By Virus
View full resource at medicalnewstoday.com
Tags: Rabies, Cancer, Children's Health, Relationship
Most Recently Shared on August 31, 2011 at 10:05 am By:
Pediatric Cancers Targeted By Virus http://mnt.to/3ZhJ #viruses #bacteria
Also Shared By:
BMC Cancer | Abstract | Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
biomedcentral.com — “The treatment of patients with malignant brain tumors remains a major oncological problem. The median survival of patients with glioblastoma multiforme (GBM), the most malignant type, is only 15 months after initial diagnosis and even less after tumor recurrence. Improvements of standard treatment including surgery and radio-chemotherapy have not lead to major improvements. Therefore, alternative therapeutics such as oncolytic viruses that specifically target and destroy cancer cells are under i” View full resource at biomedcentral.com
Most Recently Shared on March 22, 2012 at 4:39 pm By:
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (... http://t.co/kOwrrDFN
Jennerex initiates JX-594 plus irinotecan Phase 1/2 trial in metastatic colorectal cancer
news-medical.net — “Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.” View full resource at news-medical.net
Most Recently Shared on March 20, 2012 at 3:46 pm By:
Oncology News: Jennerex initiates JX-594 plus irinotecan Phase 1/2 trial in metastatic colorectal cancer: Jenner... http://t.co/MlO8mmVx
POZ - Treatment News : Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells - by Tim Horn
poz.com — “Researchers have shown for the first time that it is possible to target and interrupt the mechanism by which HIV remains hidden and unreachable by antiretroviral (ARV) drugs, according to highly anticipated study results presented Thursday, March 8, at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle. Though no people living with HIV participating in the study saw their virus eradicated as result of the experiment, the findings paint an optimistic picture for scientist” View full resource at poz.com
Most Recently Shared on March 14, 2012 at 6:12 pm By:
2 birds 1 stone? Cancer Drug Helps Purge #HIV From Resting Cells http://t.co/lcNvz5Wz @pozmagazine
AIDSmeds - Top Stories : Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells - by Tim Horn
aidsmeds.com — “Researchers have shown for the first time that it is possible to target and interrupt the mechanism by which HIV remains hidden and unreachable by antiretroviral (ARV) drugs, according to highly anticipated study results presented Thursday, March 8, at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle. Though no people living with HIV participating in the study saw their virus eradicated as result of the experiment, the findings paint an optimistic picture for scientist” View full resource at aidsmeds.com
Most Recently Shared on March 9, 2012 at 7:44 pm By:
#CROI2012 - Pathway to the Cure: Cancer Drug Helps Purge #HIV From Resting Cells http://t.co/pH5P2JJa #CROI #AIDS
Gene Identified As A New Target For Treatment Of Aggressive Childhood Eye Tumor
medicalnewstoday.com — “St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project findings help solve mystery of retinoblastoma's rapid growth in work that also yields a new treatm” View full resource at medicalnewstoday.com
Most Recently Shared on January 13, 2012 at 8:05 am By:
Gene Identified As A New Target For Treatment Of Aggressive Childhood Eye Tumor http://t.co/ZbNf8PWI #cancer
Cancer-Related Pathway Reveals Potential Treatment Target For Rare Pediatric Disease Cherubism
medicalnewstoday.com — “Cancer researchers studying genetic mutations that cause leukemia have discovered a connection to the rare disease cherubism, an inherited facial bone disorder in children.The link is t” View full resource at medicalnewstoday.com
Most Recently Shared on December 12, 2011 at 8:05 am By:
Cancer-Related Pathway Reveals Potential Treatment Target For Rare Pediatric Disease Cherubism http://t.co/gTM27fEz #lymphoma #leukemia
Defect In Cell-Targeting Ability Tames Ulcer-Causing Bacteria
medicalnewstoday.com — “Without the ability to swim to their targets in the stomach, ulcer-causing bacteria do not cause the inflammation of the stomach lining that leads to ulcers and stomach cancer, according to a new” View full resource at medicalnewstoday.com
Most Recently Shared on November 22, 2011 at 11:12 am By:
Defect In Cell-Targeting Ability Tames Ulcer-Causing Bacteria http://t.co/iG019C6U
Experimental Vaccine Against Breast, Ovarian Cancer Shows Promise - - TIME Healthland
healthland.time.com — “Dispatching cancer cells with the same precision that vaccines dismiss bacteria and viruses may soon be possible, according to scientists at the National Cancer Institute who are working on an experimental vaccine that helps the immune system target breast and ovarian cancer cells.” View full resource at healthland.time.com
Most Recently Shared on November 8, 2011 at 9:15 pm By:
An experimental injection that targets breast and ovarian cancer shows promise | http://t.co/JJNsQqYh
Jennerex commences enrollment in JX-594 Phase 2b trial for HCC
news-medical.net — “Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, together with its international commercialization partners, today announced that enrollment has been initiated and the first patient has been randomized in a Phase 2b clinical trial called TRAVERSE.” View full resource at news-medical.net
Most Recently Shared on November 4, 2011 at 8:39 am By:
Jennerex commences enrollment in JX-594 Phase 2b trial for HCC: Jennerex, Inc., a private clinical-stage biother... http://t.co/jiaVSgs8
Study identifies protein that helps measles virus spread
news-releases.uiowa.edu — “Study identifies protein that helps measles virus spread” View full resource at news-releases.uiowa.edu
Most Recently Shared on November 3, 2011 at 3:26 pm By:
Protein that helps measles spread may also make breast, ovarian and lung cancers targets for measles-based therapy http://t.co/JilDB1wM
Improving Gene Therapy For Cancer And Heart Disease
science20.com — “In gene therapy, one or more desired genes are introduced into an adenovirus, a virus that causes the common cold, which is then administered to the patient. Once in the body, the virus enters targeted cells and delivers the desired genes. In heart” View full resource at science20.com
Most Recently Shared on October 13, 2011 at 12:32 am By:
Improving Gene Therapy For Cancer And Heart Disease - In gene therapy, one or more desired genes are introduced into... http://t.co/BBUckVzi
Inner workings of virus responsible for rare skin cancer - National Cancer Institute
cancer.gov — “Scientists at the University of Pittsburgh Cancer Institute have begun to uncover how the virus that causes most Merkel cell carcinoma -- a rare and aggressive skin cancer -- operates, meaning that a rational chemotherapeutic target for this cancer could” View full resource at cancer.gov
Most Recently Shared on September 16, 2011 at 6:29 pm By:
Scientists from UPMC discover inner workings of virus responsible for rare skin cancer http://j.mp/pmW5pJ
Inner workings of virus responsible for rare skin cancer
sciencedaily.com — “Scientists have begun to uncover how the virus that causes most Merkel cell carcinoma -- a rare and aggressive skin cancer -- operates, meaning that a rational chemotherapeutic target for this cancer could be developed in the near future.” View full resource at sciencedaily.com
Most Recently Shared on September 15, 2011 at 6:19 pm By:
Inner workings of virus responsible for rare skin cancer http://t.co/IFtMGhrH
Inner workings of virus responsible for rare skin cancer
medicalxpress.com — “Scientists at the University of Pittsburgh Cancer Institute have begun to uncover how the virus that causes most Merkel cell carcinoma a rare and aggressive skin cancer operates, meaning that a rational chemotherapeutic target for this cancer could be developed in the near future.” View full resource at medicalxpress.com
Most Recently Shared on September 15, 2011 at 6:08 pm By:
Inner workings of virus responsible for rare skin cancer http://t.co/E2b21npb
Strategies For Malaria Prevention Could Substantially Cut Killer Bacterial Infections
medicalnewstoday.com — “Interventions targeting malaria, such as insecticide-treated bed nets, antimalarial drugs and mosquito control, could substantially reduce cases of bacteraemia, which kill hundreds of thousands of” View full resource at medicalnewstoday.com
Most Recently Shared on September 8, 2011 at 7:05 am By:
Strategies For Malaria Prevention Could Substantially Cut Killer Bacterial Infections http://mnt.to/3Ztt #viruses #bacteria
Advertisement



MNT Cancer News
@mnt_cancer
Gene Identified As A New Target For Treatment Of Aggressive Childhood Eye Tumor http://t.co/ZbNf8PWI #cancer
1 year ago...